Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation

Area of Science:

• Neuroscience
• Toxicology
• Immunology

Background:

• Gliotoxin (GTX) is a potent mycotoxin produced by Aspergillus fumigatus.
• GTX can damage central nervous system (CNS) cells like microglia, astrocytes, and oligodendrocytes.
• Fungal infections and mycotoxins are implicated in the initiation or exacerbation of multiple sclerosis (MS).

Purpose of the Study:

• To investigate the impact of gliotoxin (GTX) on the development of experimental autoimmune encephalomyelitis (EAE).
• To determine if GTX administered systemically can influence neuroinflammation in an EAE model.

Main Methods:

• Female C57BL/6 mice were induced with EAE using myelin oligodendrocyte glycoprotein.
• Mice received intraperitoneal injections of GTX (1 mg/kg) on days 4, 7, and 10 post-immunization.
• Clinical symptoms, neuroinflammation markers, gene expression, and cytokine production in the CNS were analyzed.

Main Results:

• GTX administration aggravated clinical symptoms of EAE in a dose-dependent manner.
• GTX treatment led to increased neuroinflammation within the CNS.
• Local analysis showed elevated inflammatory gene expression and cytokine production in the CNS.

Conclusions:

• Gliotoxin administered at a non-neuronal site can exacerbate neuroinflammation in EAE.
• These findings suggest that mycotoxins may contribute to neurological diseases through systemic effects.
• Other mycotoxins might exert deleterious effects on various neurological conditions via similar mechanisms.